title: E2F1 and E2F2 prevent replicative stress and subsequent p53-dependent organ involution.
abstract: Tissue homeostasis requires tight regulation of cellular proliferation, differentiation and apoptosis. E2F1 and E2F2 transcription factors share a critical role in tissue homeostasis, since their combined inactivation results in overall organ involution, specially affecting the pancreatic gland, which subsequently triggers diabetes. We have examined the mechanism by which these E2Fs regulate tissue homeostasis. We show that pancreas atrophy in E2F1/E2F2 double-knockout (DKO) mice is associated with mitochondrial apoptosis and activation of the p53 pathway in young animals, before the development of diabetes. A deregulated expression of E2F target genes was detected in pancreatic cells of young DKO animals, along with unscheduled DNA replication and activation of a DNA damage response. Importantly, suppression of DNA replication in vivo with aphidicolin led to a significant inhibition of the p53 pathway in DKO pancreas, implying a causal link between DNA replication stress and p53 activation in this model. We further show that activation of the p53 pathway has a key role in the aberrant phenotype of DKO mice, since targeted inactivation of p53 gene abrogated cellular apoptosis and prevented organ involution and insulin-dependent diabetes in mice lacking E2F1/E2F2. Unexpectedly, p53 inactivation unmasked oncogenic features of E2F1/E2F2-depleted cells, as evidenced by an accelerated tumor development in triple-knockout mice compared with p53(-/-) mice. Collectively, our data reveal a role for E2F1 and E2F2 as suppressors of replicative stress in differentiating cells, and uncover the existence of a robust E2F-p53 regulatory axis to enable tissue homeostasis and prevent tumorigenesis. These findings have implications in the design of approaches targeting E2F for cancer therapy.
authors: Department of Genetics, Physical Anthropology and Animal Physiology, University of the Basque Country, UPV/EHU, Bilbao, Spain.
authors: A
authors: A
authors: Iglesias-Ara
authors: Department of Genetics, Physical Anthropology and Animal Physiology, University of the Basque Country, UPV/EHU, Bilbao, Spain.
authors: O
authors: O
authors: Zenarruzabeitia
authors: University of Cantabria-IDIVAL, Cantabria, Spain.
authors: L
authors: L
authors: Buelta
authors: University of Cantabria-IDIVAL, Cantabria, Spain.
authors: J
authors: J
authors: Merino
authors: Department of Genetics, Physical Anthropology and Animal Physiology, University of the Basque Country, UPV/EHU, Bilbao, Spain.
authors: A M
authors: AM
authors: Zubiaga
mesh_terms: D000818:Animals; D017209:Apoptosis; D001284:Atrophy; D002471:Cell Transformation, Neoplastic / Q000235:genetics / Q000378:metabolism; D004261:DNA Replication; D050687:E2F1 Transcription Factor / Q000235:genetics / Q000502:physiology*; D050703:E2F2 Transcription Factor / Q000235:genetics / Q000502:physiology*; D008297:Male; D051379:Mice; D018345:Mice, Knockout; D010179:Pancreas / Q000378:metabolism* / Q000473:pathology*; D013312:Stress, Physiological / Q000235:genetics; D016159:Tumor Suppressor Protein p53 / Q000378:metabolism*
chemical_list: D050687:E2F1 Transcription Factor; D050703:E2F2 Transcription Factor; C493754:E2f1 protein, mouse; C484940:E2f2 protein, mouse; D016159:Tumor Suppressor Protein p53
references: Nature. 2002 Jan 3;415(6867):45-53
references: 11780111
references: Curr Mol Med. 2006 Nov;6(7):731-8
references: 17100599
references: Methods Cell Biol. 1978;20:361-78
references: 692437
references: Cell Cycle. 2008 Dec 15;7(24):3915-27
references: 19066456
references: Diabetologia. 2004 Mar;47(3):581-9
references: 14767595
references: Cancer Res. 2001 Oct 1;61(19):7052-5
references: 11585734
references: Cell. 1996 May 17;85(4):549-61
references: 8653790
references: Proc Natl Acad Sci U S A. 2007 Sep 25;104(39):15400-5
references: 17881568
references: Nature. 2009 Dec 17;462(7275):930-4
references: 20016602
references: Nature. 2009 Dec 17;462(7275):925-9
references: 20016601
references: Genes Dev. 2004 Jun 15;18(12):1413-22
references: 15175242
references: Biochem Biophys Res Commun. 1993 Nov 30;197(1):40-5
references: 8250945
references: Cancer Res. 1994 Feb 1;54(3):724-9
references: 8306334
references: Nat Med. 2000 Feb;6(2):171-6
references: 10655105
references: J Clin Invest. 2003 Apr;111(8):1147-60
references: 12697734
references: Diabetes. 2001 Jul;50(7):1553-61
references: 11423476
references: Cell. 1995 May 5;81(3):323-30
references: 7736585
references: Cancer Res. 2008 Aug 1;68(15):6292-9
references: 18676853
references: Proc Natl Acad Sci U S A. 2003 Oct 28;100(22):12935-40
references: 14566047
references: Immunity. 2001 Dec;15(6):959-70
references: 11754817
references: Cell. 2000 Jan 7;100(1):57-70
references: 10647931
references: Eur J Cancer. 2005 Nov;41(16):2403-14
references: 16213134
references: Curr Opin Genet Dev. 1998 Feb;8(1):28-35
references: 9529602
references: Nat Rev Mol Cell Biol. 2002 Jan;3(1):11-20
references: 11823794
references: Cell. 2011 Apr 29;145(3):435-46
references: 21529715
references: Nature. 2008 Sep 25;455(7212):552-6
references: 18794899
references: Antioxid Redox Signal. 2005 Mar-Apr;7(3-4):367-84
references: 15706084
references: EMBO J. 2004 Dec 8;23(24):4709-16
references: 15538380
references: Nucleic Acids Res. 2012 Jan;40(2):477-86
references: 21937510
references: Mol Cell Biol. 1995 Aug;15(8):4215-24
references: 7623816
references: J Am Geriatr Soc. 2002 Sep;50(9):1561-5
references: 12383155
references: J Biol Chem. 2004 Mar 12;279(11):10476-83
references: 14684733
references: J Clin Invest. 2002 Feb;109(4):525-32
references: 11854325
references: Nucleic Acids Res. 2004;32(1):25-34
references: 14704340
references: Wiley Interdiscip Rev Dev Biol. 2012 Sep-Oct;1(5):731-41
references: 22960768
references: Nucleic Acids Res. 2011 May;39(9):3558-73
references: 21247883
references: Nucleic Acids Res. 2007;35(22):7475-84
references: 17942417
references: Eur J Clin Invest. 2007 Oct;37(10):791-801
references: 17888090
references: J Neurosci. 2007 Feb 7;27(6):1434-44
references: 17287518
references: Nat Rev Cancer. 2008 Jul;8(7):512-22
references: 18574463
references: Nat Rev Mol Cell Biol. 2008 Sep;9(9):713-24
references: 18719710
references: Genes Dev. 2001 Feb 1;15(3):267-85
references: 11159908
references: Mol Cancer. 2012;11:24
references: 22537161
references: Oncotarget. 2014 Feb 28;5(4):901-7
references: 24658650
references: Nature. 1992 Mar 19;356(6366):215-21
references: 1552940
references: Mol Cell. 2001 Jun;7(6):1153-63
references: 11430819
references: J Biol Chem. 2006 Nov 24;281(47):36124-31
references: 17008321
references: J Cell Biol. 2010 Mar 8;188(5):629-38
references: 20194642
references: Mol Cell Biol. 2010 Jun;30(12):2983-95
references: 20404092
references: Mol Cell Biol. 2012 Oct;32(20):4226-36
references: 22907750
references: J Biomed Biotechnol. 2002;2(2):46-54
references: 12488583
references: Oncogene. 2010 Oct 14;29(41):5579-90
references: 20676136
references: Biochem Biophys Res Commun. 1989 Oct 16;164(1):185-90
references: 2478126
references: J Clin Invest. 2004 May;113(10):1398-407
references: 15146237
references: Mol Cell. 2006 Nov 3;24(3):433-43
references: 17081992
references: Nat Genet. 2013 Aug;45(8):947-50
references: 23770608
references: Horm Res. 2004;62 Suppl 3:67-73
references: 15539803